A summary of goodwill by segment and related adjustments is provided below:


	Goodwill
	Hospice			Personal Care		Home Health		Total
	(Amounts In Thousands)
Goodwill at December 31, 2020	$	314,833		$	152,448	$	1,791	$	469,072
Additions for acquisitions		13,370			115		21,579		35,064
Adjustments to previously recorded goodwill		131			125		—		256
Goodwill at December 31, 2021		328,334			152,688		23,370		504,392
Additions for acquisitions		69,446			—		8,910		78,356
Adjustments to previously recorded goodwill		(52	)		—		141		89
Goodwill at December 31, 2022	$	397,728		$	152,688	$	32,421	$	582,837

In 2022, the Company recognized goodwill in the hospice segment of $69.4 million related to the acquisition of JourneyCare and $8.9 million with the acquisition of Apple Home in the home health segment. In connection with the acquisition of Armada in 2021, the Company recognized goodwill in its hospice and home health segments of $13.4 million and $15.0 million, respectively, and $6.5 million with the acquisition of Summit in 2021 in our home health segment.

Goodwill adjustments to previously recorded goodwill are generally related to accounts receivable and accrued expenses based on the final valuations. See Note 3 to the Notes to Consolidated Financial Statements for additional information regarding the acquisitions made by the Company in 2021 and 2022.

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names and trademarks, non-competition agreements and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from one to twenty-five years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from five to ten years.

Goodwill and certain state licenses are not amortized pursuant to ASC Topic 350. We test intangible assets with indefinite useful lives for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred. The Company estimates the fair value of the reporting unit using both a discounted cash flow model as well as a market multiple model. The cash flow forecasts are adjusted by an appropriate discount rate based on the Company’s estimate of a market participant’s weighted-average cost of capital. These models are both based on the Company’s best estimate of future revenues and operating costs and are reconciled to the Company’s consolidated market capitalization, with consideration of the amount a potential acquirer would be required to pay, in the form of a control premium. The determination of fair value in the Company’s goodwill impairment analysis is based on an estimate of fair value for each reporting unit utilizing known and estimated inputs at the evaluation date. Some of those inputs include, but are not limited to, the most recent price of the Company’s common stock and fair value of long term debt, estimates of future revenue and expense growth, estimated market multiples, expected capital expenditures, income tax rates and cost of invested capital. Significant assumptions used in the analysis included a 9.5% discount rate and long-term revenue growth rates that ranged from 3.5% to 7.0%. For the fiscal year 2022 impairment test, the fair value of the reporting units exceeded their respective carrying values (commonly referred to as “headroom”) by at least 100% in the personal care segment, by 75% in the home health segment, and 67% in the hospice segment. The Company did not record any impairment charges for the years ended December 31, 2022, 2021 or 2020.

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following at December 31, 2022 and 2021:


	Customer and referral relationships			Trade names and trademarks			Non- competition agreements			State Licenses			Total
	(Amounts in Thousands)
Intangible assets with indefinite lives	$	—		$	—		$	—		$	27,108		$	27,108
Intangible assets subject to amortization:
Gross carrying amount		44,672			52,046			6,785			12,517			116,020
Accumulated amortization		(38,088	)		(21,058	)		(4,785	)		(7,009	)		(70,940	)
Intangible assets subject to amortization, net		6,584			30,988			2,000			5,508			45,080
Net balance at December 31, 2022	$	6,584		$	30,988		$	2,000		$	32,616		$	72,188

Intangible assets with indefinite lives	$	—		$	—		$	—		$	21,124		$	21,124
Intangible assets subject to amortization:
Gross carrying amount		44,672			42,926			6,785			12,508			106,891
Accumulated amortization		(36,342	)		(18,494	)		(3,831	)		(5,027	)		(63,694	)
Intangible assets subject to amortization, net		8,330			24,432			2,954			7,481			43,197
Net balance at December 31, 2021	$	8,330		$	24,432		$	2,954		$	28,605		$	64,321

During the year ended December 31, 2022, the Company acquired indefinite-lived state licenses and trade names of $4.8 million and $9.0 million, respectively, related to the acquisition of JourneyCare. During the year ended December 31, 2022, the Company acquired indefinite lived state licenses and trade names of $1.2 million and $0.1 million, respectively, related to the acquisition of Apple Home.

During the year ended December 31, 2021, the Company acquired indefinite lived state licenses and non-competition agreements of $0.4 million and $0.6 million, respectively, related to the acquisition of Armada.

Amortization expense related to the identifiable intangible assets amounted to $7.2 million, $8.5 million and $7.1 million for the years ended December 31, 2022, 2021 and 2020, respectively.

The weighted average remaining useful life of identifiable intangible assets as of December 31, 2022 is 9.8 years.